This study compares cannabidiol (CBD) to the standard antipsychotic risperidone in 64 adults with schizophrenia or related psychotic disorders who have used cannabis. The goal is to see if CBD can reduce psychotic symptoms and help people stop or cut down cannabis use. Participan…
Phase: PHASE2 • Sponsor: Lone Baandrup • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC